David R. Ramsay Net Worth & Insider Trades
David R. Ramsay - Director, Vanda Pharmaceuticals Inc
What is David R. Ramsay's Net Worth?
The current estimated net worth of Vanda Pharmaceuticals Inc's Director, David R. Ramsay, is estimated to be about $86.79M . David R. Ramsay owns about 200,000 units of Vanda Pharmaceuticals Inc common stock. In the last 3 years at Vanda Pharmaceuticals Inc, David R. Ramsay has sold an estimated value of $63.96M worth.
What is David R. Ramsay's Past Insider Trading?
David R. Ramsay's largest sale order was 437,000 units , worth over $11.81M on February 22, 2007. In total, David R. Ramsay has made about 15 transactions over 3 years of their time at Vanda Pharmaceuticals Inc. David R. Ramsay usually trades in November and December, with the busiest year in 2006. The most recent transaction was a sale order of 228,924 units , worth over $2.54M on December 16, 2009.
David Ramsay
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is David R. Ramsay's' Mailing Address?
- Mailing address is Care Capital Llc 47 Hulfish St., Suite 310 Princeton NJ 08542 NJ
Vanda Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Mihael H. Polymeropoulos, M.D. | 2020 | $746,235 | - | $679,200 | $795,830 | $656,687 | $35,468 | $2,913,420 |
| Mihael H. Polymeropoulos, M.D. | 2019 | $721,000 | - | $1,237,200 | $1,610,154 | $675,000 | $34,783 | $4,278,137 |
| Mihael H. Polymeropoulos, M.D. | 2018 | $700,000 | - | $1,131,000 | $1,456,406 | $700,000 | $37,322 | $4,024,728 |
| James P. Kelly | 2020 | $124,057 | - | - | - | - | $16,217 | $140,274 |
| James P. Kelly | 2019 | $493,370 | - | $618,600 | $805,077 | $288,622 | $42,741 | $2,248,410 |
| James P. Kelly | 2018 | $479,000 | - | $754,000 | $832,232 | $299,375 | $36,778 | $2,401,385 |
| Kevin Moran | 2020 | $324,693 | - | $331,101 | $427,779 | $200,000 | $36,126 | $1,319,699 |
| Joakim Wijkstrom | 2020 | $506,422 | - | $339,600 | $397,915 | $250,679 | $29,269 | $1,523,885 |
| Aranthan "AJ" Jones II | 2020 | $406,104 | - | $339,600 | $397,915 | $201,021 | $33,677 | $1,378,317 |
| Timothy Williams | 2020 | $400,000 | - | $339,600 | $397,915 | $200,000 | $41,546 | $1,379,061 |
| Timothy Williams | 2019 | $379,315 | - | $618,600 | $805,077 | $177,520 | $42,342 | $2,022,854 |
| Timothy Williams | 2018 | $144,886 | $40,000 | $643,500 | $1,086,894 | $71,918 | $15,658 | $2,002,856 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1347178/000134717821000008/vnda-20210422xdef14a.htm
What are Vanda Pharmaceuticals Inc's Past Insider Trades?
Vanda Pharmaceuticals Inc's most recent insider trade came on December 16, 2022 by Timothy Williams who sold 8,000 units worth $56.07K . In the last 16 years, insiders at Vanda Pharmaceuticals Inc have sold an estimated value of $297.21M and bought an estimated value of $28.74M worth of shares. Insider trading is most common in June, with the busiest year in 2006. The most active traders at the company are Mihael Polymeropoulos, President and CEO, James P. Kelly, EVP & Chief Financial Officer, and Richard W Dugan, Director .
Vanda Pharmaceuticals Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||